Drugs · acquisition-cost intelligence
TRI-LUMA
fluocinolone acetonide, hydroquinone, and tretinoin· ingredient tretinoinCorticosteroids· FLUOCINOLONE ACETONIDE .1 mg/g; HYDROQUINONE 40 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$7.82
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other tretinoin products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Retin-A | $0.86759 | −$6.95 |
| tretinoin | $0.94183 | −$6.88 |
| tretinoin | $1.26 | −$6.56 |
| Tretinoin | $3.04 | −$4.79 |
| Atralin | $4.23 | −$3.60 |
| Clindamycin Phosphate 1.2% and Tretinoin 0.025% | $4.30 | −$3.52 |
| Tretinoin (Microsphere) | $8.71 | +$0.88660 |
| Tretinoin | $9.65 | +$1.83 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.